Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Conditions
Retroperitoneal Liposarcoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Emory Winship Cancer Institute, Atlanta, Georgia, United States
Contact: Principal Investigator (Kenneth Cardona)Brigham and Women's Hospital, Boston, Massachusetts, United States
Contact: Principal Investigator (Chandrajit Raut)OSU James Hospital, Columbus, Ohio, United States
Contact: Principal Investigator (David Konieczkowski)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Christina Roland)Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
Contact: Principal Investigator (Angela Hong)Prince of Wales Hospital, Randwick, New South Wales, Australia
Contact: Study coordinator (Diana Nawara) · seslhd-sarcomadatamanager@health.nsw.gov.au · 61293822222Contact: Principal Investigator (Yeh Chen Lee)Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Principal Investigator (David Gyorki)UZ Leuven, Leuven, Flemish Brabant, Belgium
Contact: Principal Investigator (Daphne Hompes)A.C.Camargo Cancer Center - Fundacao Antonio Prudente, Liberdade, São Paulo, Brazil
Contact: Principal Investigator (Samuel Aguiar Junior)The Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Charles Catton)Institut Curie Hospital, Paris, France
Contact: Principal Investigator (Dimitri Tzanis)The Netherlands Cancer Institute, Amsterdam, North Holland, Netherlands
Contact: Principal Investigator (Rick Haas)Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
Contact: Principal Investigator (Mateusz Spalek)
Study leads
Angela Hong
Principal Investigator
Chris O'Brien Lifehouse